A case-control study that prospectively assessed whether plasma levels of inflammatory markers such as CRP, TNF-α, IL-6, leptin, and adiponectin were associated with breast cancer risk showed no significant association between these inflammatory markers and breast cancer risk but found significant interactions between menopausal status and plasma levels. This evidence concerns the gene TNF and breast carcinoma.